Skip to main content

Advertisement

Log in

PTP1B expression contributes to gastric cancer progression

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Protein tyrosine phosphatase 1B (PTP1B), a member of the superfamily of protein tyrosine phosphatases, has been implicated in cancer pathogenesis. However, the role of PTP1B in the development of gastric cancer is unclear. The purpose of this study was to clarify the expression pattern and role of PTP1B in the gastric cancer. The expression of PTP1B in gastric cancer tissues was determined by immunohistochemical staining. Cell growth assay, soft agar colony formation assay, and tumorigenicity assay were used for examining proliferation, colony formation, and in vivo tumorigenesis of gastric cancer cells. The total levels and phosphorylated levels of Akt, extracellular signal-regulated kinase (Erk1/2), focal adhesion kinase (FAK), and Src were examined by western blotting, respectively. PTP1B was overexpressed in gastric cancer tissues (65/80) and correlated with tumor metastasis and tumor-node-metastasis stage. Overexpression of PTP1B promoted the proliferation and in vivo tumorigenesis of MKN45 cells and also increased the phosphorylation levels of Akt, Erk1/2, and FAK and the activity of Src. These results were conformed by knockdown of PTP1B in MKN28 cells. Therefore, our study suggested that PTP1B expression might play an important role in the development of gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Motiwala T, Jacob ST. Role of protein tyrosine phosphatases in cancer. Prog Nucleic Acid Res Mol Biol. 2006;81:297–329.

    Article  PubMed  CAS  Google Scholar 

  2. Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem. 1988;263:6722–30.

    PubMed  CAS  Google Scholar 

  3. Buffart TE, et al. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch. 2009;455:213–23.

    Article  PubMed  CAS  Google Scholar 

  4. Scotto L, et al. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer. 2008;47:755–65.

    Article  PubMed  CAS  Google Scholar 

  5. Warabi M, Nemoto T, Ohashi K, Kitagawa M, Hirokawa K. Expression of protein tyrosine phosphatases and its significance in esophageal cancer. Exp Mol Pathol. 2000;68:187–95.

    Article  PubMed  CAS  Google Scholar 

  6. Brown-Shimer S, Johnson KA, Hill DE, Bruskin AM. Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res. 1992;52:478–82.

    PubMed  CAS  Google Scholar 

  7. Zhai YF, et al. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res. 1993;53:2272–8.

    PubMed  CAS  Google Scholar 

  8. Wiener JR, et al. Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas. Am J Obstet Gynecol. 1994;170:1177–83.

    PubMed  CAS  Google Scholar 

  9. Zhu S, Bjorge JD, Fujita DJ. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res. 2007;67:10129–37.

    Article  PubMed  CAS  Google Scholar 

  10. Julien SG, et al. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet. 2007;39:338–46.

    Article  PubMed  CAS  Google Scholar 

  11. Dubé N, et al. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p-53-null mice through the regulation of B-cell development. Cancer Res. 2005;65:10088–95.

    Article  PubMed  Google Scholar 

  12. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14:ii31–6.

    PubMed  Google Scholar 

  13. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5:5–11.

    Article  PubMed  Google Scholar 

  14. Boyle P, Levin B. World Cancer Report (2008) from the World Health Organization, worldwide cancer burden. Published by International Agency for Research on Cancer 2008.

  15. Wang YW, et al. In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity. Clin Cancer Res. 2006;12:4965–73.

    Article  PubMed  CAS  Google Scholar 

  16. Jiang Y, et al. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 2004;21:755–64.

    Article  PubMed  CAS  Google Scholar 

  17. Wang J, Chen X, Liu B, Zhu Z. Suppression of PTP1B in gastric cancer cells in vitro induces a change in the genome-wide expression profile, and inhibits gastric cancer cell growth. Cell Biol Int. 2010;34:747–53.

    Article  PubMed  CAS  Google Scholar 

  18. Tu SP, et al. Suppression of survival expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 2003;63:7724–32.

    PubMed  CAS  Google Scholar 

  19. Arias-Romero LE, et al. Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 2009;69:4582–8.

    Article  PubMed  CAS  Google Scholar 

  20. Yang SH, et al. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res. 2005;11:612–20.

    PubMed  CAS  Google Scholar 

  21. Dubé N, Cheng A, Tremblay ML. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci USA. 2004;101:1834–9.

    Article  PubMed  Google Scholar 

  22. Liu SQ, Yu JP, Yu HG, Lv P, Chen HI. Activation of Akt and ERK signaling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Dig Liver Dis. 2006;38:310–8.

    Article  PubMed  CAS  Google Scholar 

  23. Bjorge JD, Pang A, Fujita DJ. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem. 2000;275:41439–46.

    Article  PubMed  CAS  Google Scholar 

  24. Stuible M, Doody KM, Tremblay ML. PTP1B and TC-PTP: regulators of transformation and tumorigenesis. Cancer Metastasis Rev. 2008;27:215–30.

    Article  PubMed  CAS  Google Scholar 

  25. Liang FB, Lee SY, Liang J, Lawrence DS, Zhang ZY. The role of protein-tyrosine phosphatase 1B in integrin signaling. J Biol Chem. 2005;280:24857–63.

    Article  PubMed  CAS  Google Scholar 

  26. Arregui CO, Balsamo J, Lilien J. Impaired integrin mediated adhesion and signaling in fibroblasts expressing a dominant-negative mutant PTP1B. J Cell Biol. 1998;143:861–73.

    Article  PubMed  CAS  Google Scholar 

  27. Cheng A, Bal GS, Kennedy BP, Tremblay ML. Attenuation of adhesion-dependent signaling and cell spreading in transformed fibroblasts lacking protein tyrosine phosphatase-1B. J Biol Chem. 2001;276:25848–55.

    Article  PubMed  CAS  Google Scholar 

  28. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 2003;22:337–58.

    Article  PubMed  CAS  Google Scholar 

  29. Sachdev S, Bu Y, Gelman IH. Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. BMC Cancer. 2009;9:12.

    Article  PubMed  Google Scholar 

  30. Zhang ZY, Lee SY. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs. 2003;12:223–33.

    Article  PubMed  CAS  Google Scholar 

  31. Zhang S, Zhang ZY. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today. 2007;12:373–81.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported in part by the grant of Science and Technology Commission of Shanghai Municipality No. 07jc14041.

Conflict of interest

We declare that we have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhenggang Zhu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, J., Liu, B., Chen, X. et al. PTP1B expression contributes to gastric cancer progression. Med Oncol 29, 948–956 (2012). https://doi.org/10.1007/s12032-011-9911-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-9911-2

Keywords

Navigation